A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy

INTRODUCTION: Vaginal tenofovir (TFV) 1% gel may reduce incident HIV-1 and herpes simplex virus 2 infection. Pregnancy may increase risk of HIV acquisition, and incident HIV in pregnancy potentiates perinatal HIV transmission. Our objective was to investigate the safety and pharmacokinetics of seven...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int AIDS Soc
Main Authors: Beigi, Richard H, Noguchi, Lisa M, Montgomery, Elizabeth, Biggio, Joseph, Hendrix, Craig W, Marzinke, Mark A, Dai, James Y, Pan, Jason, Na Ayudhya, Ratiya Kunjara, Schwartz, Jill L, Isaacs, Karen, Piper, Jeanna M, Watts, D Heather
Formato: Artigo
Idioma:Inglês
Publicado em: International AIDS Society 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5034095/
https://ncbi.nlm.nih.gov/pubmed/27658440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7448/IAS.19.1.20990
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados